• Latest Posts

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

Seven pharma companies form alliance to prepare for future pandemics 

FDA approves Genentech’s lymphoma drug

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

Roche doubles down in Fight against Antibiotic Resistance

Roche drops Partnership for Hepatitis Immunotherapy


Biosimilars set to take on Oncology after a new Market Authorization

The Top 12 Biotech Leaders You Should Know in Basel

Sysnav and Roche partner on movement tracking technology

In Depth 17 Jan 2023

Cell and gene therapies gain momentum in Basel

FDA clears insulin pen medical device